• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 217/02 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ringAlkylene-bis-isoquinolines

Patent holdings for IPC class C07D 217/02

Total number of patents in this class: 391

10-year publication summary

26
22
28
18
25
23
19
19
18
7
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Alcon, Inc.
5434
28
Bausch + Lomb Ireland Limited
695
9
Pfizer Inc.
3371
7
Centre National de La Recherche Scientifique
10464
7
D. Western Therapeutics Institute, Inc.
19
7
Universite de Montpellier
989
7
Aerie Pharmaceuticals, Inc.
42
6
Janssen Pharmaceutica N.V.
3394
5
Abivax
120
5
Alcon, Inc.
355
5
Institut Curie
585
5
SpecGx LLC
188
5
Bristol-myers Squibb Company
4880
4
The Regents of the University of California
19961
4
Merck Patent GmbH
5815
4
Epizyme, Inc.
373
4
Icahn School of Medicine at Mount Sinai
951
4
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin
165
4
The University of Queensland
661
4
Fosun Orinove Pharmatech, Inc.
13
4
Other owners 263